09/30/2026
COFFEE & YOUR HEALTH — WHAT THE EVIDENCE REALLY SAYS ☕
Coffee is not simply “good” or “bad.” The physiologic effect depends on dose, brewing method, timing, genetics, sleep vulnerability, cardiovascular phenotype and what is added to the cup.
Across large observational datasets, moderate intake — often around 3–4 cups/day — is associated with lower all-cause and cardiovascular mortality and a lower risk of type 2 diabetes. But association is not the same as prescription.
One of the most practical findings is about brewing: paper filtration substantially lowers exposure to coffee diterpenes such as cafestol and kahweol, which can raise LDL cholesterol. For patients with lipid concerns, filtered drip or pour-over is a reasonable default.
Medium roast is a pragmatic choice, not a proven “healthiest roast.” Roasting changes chlorogenic acids and other compounds, but clinical outcome data comparing roast levels remain limited.
Caffeine response is also highly individual. CYP1A2 influences caffeine metabolism, while ADORA2A variants may influence caffeine sensitivity and anxiety. Your actual phenotype — sleep, blood pressure, palpitations, anxiety and timing response — matters more than a single SNP.
And coffee changes more than alertness. In the randomized CRAVE trial, coffee days were associated with more steps, less sleep and more PVCs, while PACs were not significantly increased.
My practical VitalSight approach:
• shade-grown + traceable coffee
• medium roast
• paper-filtered drip or pour-over
• dose caffeine intentionally
• drink it earlier when sleep is vulnerable
• use decaf strategically
• measure your own response
Selected studies: Poole et al., BMJ 2017; Ding et al., Diabetes Care 2014; Bak & Grobbee, NEJM 1989; Cornelis et al., JAMA 2006; Alsene et al., Neuropsychopharmacology 2003; Marcus et al., NEJM 2023.
Educational content only; not individualized medical advice.
MetabolicHealth HeartHealth SleepHealth PreventiveMedicine LifestyleMedicine ShadeGrownCoffee SustainableCoffee